<DOC>
	<DOCNO>NCT01300156</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety combination chemotherapy etoposide , methylprednisolone , high-dose cytarabine oxaliplatin ( ESHAOx ) patient refractory relapsed Hodgkin 's lymphoma ( HL ) .</brief_summary>
	<brief_title>Etoposide , Methylprednisolone , High-dose Cytarabine Oxaliplatin ( ESHAOx ) Refractory Relapsed Hodgkin 's Lymphoma ( HL )</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Previously histologically confirm Hodgkin 's lymphoma Failure achieve complete remission initial induction chemotherapy , recurrent disease Performance status ( ECOG ) ≤ 3 Age ≤ 75 year old Number prior chemotherapy : one two regimen At least one unidimensionally measurable lesion ( ) define ; ≥ 2 cm conventional CT ≥ 1 cm spiral CT skin lesion ( photograph take ) measurable lesion physical examination Adequate organ function define ; ANC &gt; 1,500/ul , platelet &gt; 75,000/ul , transaminase &lt; 3 X upper normal value ; bilirubin &lt; 2 mg/dL Written inform consent approve institutional review board ethic committee Previous high dose chemotherapy autologous stem cell transplantation allogeneic stem cell transplantation Previous chemotherapy ESHAP regimen Any malignancy within past 5 year except skin basal cell carcinoma carcinoma situ cervix Other serious illness medical condition Unstable cardiac disease despite treatment , myocardial infarction within 6 month prior study entry History significant neurologic psychiatric disorder include dementia seizure Active uncontrolled infection ( viral , bacterial fungal infection ) Other serious medical illness Pregnancy breastfeeding , woman childbearing potential employ adequate contraception Previous history drug allergy one drug study regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Hodgkin 's disease</keyword>
	<keyword>lymphoma</keyword>
	<keyword>Relapsed</keyword>
	<keyword>refractory</keyword>
</DOC>